ONZETRA XSAIL (nda206099)- (EQ 11MG BASE)

Generic Name	SUMATRIPTAN SUCCINATE	Innovator	CURRAX
Dosage	EQ 11MG BASE
ParaIV Filing	No	505(b)2 Filing	Yes
Last Patent Expiry	2034-Oct-20	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	ONZETRA Xsail is a serotonin 5-HT1B/1D receptor agonist (triptan) indicated for the acute treatment of migraine with or without aura in adults.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	None

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
EQ 11MG BASE	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
Yes	0

Manufacturing Details of ONZETRA XSAIL